about
A qualitative exploration of the major challenges facing pharmacovigilance in Saudi Arabia.Perspectives on the future of postmarket vaccine safety surveillance and evaluation.Performance assessment of the Thai National Center for Pharmacovigilance.Safety reporting through a comprehensive and pragmatic pharmcovigilance process for India and emerging markets: an industry perspective.Collaboration in pharmacovigilance: lamotrigine and fatal severe cutaneous adverse reactions - a review of spontaneous reports.A global view of undergraduate education in pharmacovigilance.
P2860
description
2014 nî lūn-bûn
@nan
2014 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2014 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2014年の論文
@ja
2014年論文
@yue
2014年論文
@zh-hant
2014年論文
@zh-hk
2014年論文
@zh-mo
2014年論文
@zh-tw
2014年论文
@wuu
name
Ongoing challenges in pharmacovigilance.
@ast
Ongoing challenges in pharmacovigilance.
@en
Ongoing challenges in pharmacovigilance.
@nl
type
label
Ongoing challenges in pharmacovigilance.
@ast
Ongoing challenges in pharmacovigilance.
@en
Ongoing challenges in pharmacovigilance.
@nl
prefLabel
Ongoing challenges in pharmacovigilance.
@ast
Ongoing challenges in pharmacovigilance.
@en
Ongoing challenges in pharmacovigilance.
@nl
P2860
P1433
P1476
Ongoing challenges in pharmacovigilance.
@en
P2093
Gerald J Dal Pan
P2860
P2888
P356
10.1007/S40264-013-0123-X
P577
2014-01-01T00:00:00Z
P5875
P6179
1033888109